Clinical Trials
Leading Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data
The EndPandemic National Data Consortium announced that it has received commitments from six leading life sciences and information technology companies to join the Consortium,...
Clinical Trials
APEIRON Biologics InitiatesPhase II Clinical Trial of APN01 for Treatment of COVID-19
APEIRON Biologics AG announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01...
Clinical Trials
Ergomed Announces Provision of Clinical Research Services for Second COVID-19
Ergomed plc , a company focused on providing specialised services to the pharmaceutical industry, announces it is providing support for a clinical development programme...
Clinical Trials
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus...
Articles
Putting the Patient First: Not Just When It’s Convenient
Introduction
Successful clinical trials rely on effective patient recruitment and retention. However, a 2019 report indicates that the industry continues to struggle meeting these objectives....
Clinical Trials
CluePoints Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has seen a dramatic...
Clinical Trials
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read